A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

Summary

VH4770359 (also known as GSK4770359) is an antiretroviral compound. This first-in-human study aims to evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered VH4770359 in healthy participants. The findings from this study will support the design of future clinical studies of VH4770359 in people living with HIV.

Timeline

Start

2026-05-14

Primary completion

2027-05-05

Completion

2027-05-05

Drugs

Indications